ANI PHARMACEUTICALS INC — Director's Dealing 2020

Mar 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-03-03

Reporting Person: HAUGHEY THOMAS (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-03-03	Common Stock	P	2000	$45.18	Acquired	8291	Direct
2020-03-04	Common Stock	P	3000	$45.05	Acquired	11291	Direct

Footnotes

F1: The shares were acquired in multiple trades at prices ranging from $45.1012 to $45.29. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F2: The shares were acquired in multiple trades at prices ranging from $44.88 to $45.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.